| http://www.w3.org/ns/prov#value | - We believe the outside-in approach will potentially better target the localized injury caused by vascular procedures such as balloon angioplasty or atherectomy, explained Mercator Chief Executive Officer Thomas M. Loarie.Immediately following the first procedure, Dr. Harlin said he believes Mercators Micro-Infusion Device returns therapeutic freedom back to the physician.
|
